Back to Archived Journals » Oncolytic Virotherapy » Volume 4

Myxoma virus attenuates expression of activating transcription factor 4 (ATF4) which has implications for the treatment of proteasome inhibitor–resistant multiple myeloma

Total article views   HTML views PDF downloads Totals
8,593 Dovepress* 8,254+ 1,284 9,538
PubMed Central* 339 97 436
Totals 8,593 1,381 9,974
*Since 13 January 2015
+Since July 2016

View citations on PubMed Central and Google Scholar